Amino Acids & Building Blocks(氨基酸 & 组成单元)
- Peptide Coupling Reagents(23)
- Amino Acids and Derivatives(324)
- Unusual Amino Acids(228)
- N-Methyl Amino Acids(27)
- Boc-Amino Acids and Derivative(149)
- Fmoc-Amino Acids and Derivatives(194)
- Z-Amino Acids and Derivatives(105)
- Amino Alcohols(82)
- N-Protecting Reagents(11)
- Linkers for Solid Phase Synthesis(7)
- Amino Acids 2-Chlorotrityl Resin(28)
- Other Reagents(17)
- Other Resin and Derivatives(16)
- Others(207)
- Cat.No. 产品名称 Information
-
GC63781
(R)-BAY-899
-
GC63768
Oxythiamine diphosphate ammonium
-
GC63748
SPOP-IN-6b dihydrochloride
-
GC63712
XL388-C2-amide-PEG9-NH2 hydrochloride
-
GC63698
Leucomalachite green-d5
-
GC63697
BSc3094
-
GC63685
(6R,7S)-Cefminox sodium heptahydrate
-
GC63677
VPC-80051 racemate
VPC-80051 is an potent inhibitor of hnRNP A1 splicing activity that targets hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line.
-
GC63673
ABT-384
-
GC63665
Benzylacyclouridine
-
GC63657
N,N,N′,N′-Tetracyclohexyl-3-oxapentanediamide
A calcium ionophore
-
GC63638
Acetone-d6
-
GC63637
Esfenvalerate
-
GC63633
N7-Methyl-guanosine-5’-triphosphate-5’-adenosine
-
GC63629
cis-2-Butene-1,4-diol
-
GC63626
ZINC05007751
ZINC05007751 is a potent NIMA-related kinase NEK6 inhibitor with an IC50 of 3.4 μM, shows antiproliferative activity against a panel of human cancer cell lines and displays a synergistic effect with Cisplatin and Paclitaxel in a BRCA2 mutated ovarian cancer cell line. DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
-
GC63625
N-Palmitoyl-L-glutamine
-
GC63618
Antrafenine
-
GC63614
Trichloroacetonitrile
-
GC63600
Piperonyl alcohol
-
GC63589
NSC668394
-
GC63588
Palmitoyl glutamic acid
-
GC63587
Dichlormid
-
GC63586
FR054
FR054 is a novel inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3 with a remarkable anti-breast cancer effect.
-
GC63573
Cannabigerol monomethyl ether
An Analytical Reference Standard
-
GC63557
PW0787
-
GC63553
PTPN22-IN-1
-
GC63551
AZD-CO-Ph-PEG4-Ph-CO-AZD
-
GC63542
L-Histidine benzyl ester bistosylate
-
GC63535
ALV2
-
GC63530
Acid Ceramidase-IN-1
-
GC63526
(S)-ErSO
-
GC63525
Valiloxibic acid
-
GC63510
BPK-25
-
GC63509
BPK-21
-
GC63508
R-(+)-Mono-desmethylsibutramine
-
GC63506
Curcumin-β-D-glucuronide
-
GC63493
ELOVL1-IN-1
An inhibitor of ELOVL1
-
GC63488
Ethaselen
-
GC63480
Obafistat
-
GC63475
Deltamethrin-d5
An internal standard for the quantification of deltamethrin
-
GC63424
Givosiran
-
GC63420
ABR-238901
ABR-238901 is a novel S100A8/A9 blocker that potently inhibits S100A8/A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll-like receptor 4).
-
GC63409
SG3199-Val-Ala-PAB
-
GC63401
BPH-652
-
GC63368
Patisiran sodium
-
GC63361
CR-1-30-B
-
GC63347
Peptide 78
-
GC63344
PFM39
-
GC63339
OSBPL7-IN-1